Donald Trump has declared India might face retaliation if New Delhi doesn’t clear the export of Hydroxychloroquine, an anti-malarial drug that the United States President has touted as a “game-changer” in the battle against coronavirus. Speaking to press at White House, Trump said he would be “surprised” if India turns down Washington’s request, more so because both countries share amicable relations. India is one of the largest manufacturers of Hydroxychloroquine and recently it banned its export, along with other key drugs. The idea is to have enough in stock for domestic use even as its efficacy in battling COVID-19 is being judged. Hydroxychloroquine was put under blanket ban disallowing its export even on humanitarian grounds. Last weekend, Trump called Prime Minister Narendra Modi. The Nation Over 300 researchers from the Observational Health Data Sciences and Informatics (OHDSI) international community have declared hydroxychloroquine safe, but caution that its effectiveness is still unknown. In the face of the rapid spread and escalation of the coronavirus, many decisions are being made quickly and a number of therapies are… April 6, 2020 In "News" Dr. Vladimir Zelenko provides important update on three drug regimen of Hydroxychloroquine Sulfate, Zinc and Azithromycin (Z-Pak) he used to effectively treat 699 coronavirus patients with 100% success Last Wednesday, we published the success story from Dr. Vladimir Zelenko, a board-certified family practitioner in New York, after he successfully treated… April 1, 2020 In "News" The Food and Drug Administration on Sunday (FDA) has given an approval for a pair of anti-malaria drugs to be used in the treatment of coronavirus. TheHill reported that the Health and Human Services Department (HHS) said in a statement that the authorization would allow 30 million doses of hydroxychloroquine… March 30, 2020 In "News"